Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

17.74

+1.67 (10.39%)

At close: May 29, 2025, 4:00 PM

16.86

-0.88 (-4.96%)

After-hours: May 29, 2025, 7:58 PM EDT

Enliven Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	101.71	124.12	100.14	75.54	110.02	130.37
Short-Term Investments	187.85	189.32	153.01	-	-	-
Cash & Short-Term Investments	289.56	313.44	253.15	75.54	110.02	130.37
Cash Growth	-9.66%	23.82%	235.14%	-31.35%	-15.60%	-
Prepaid Expenses	4.76	4.63	2.95	2.22	0.65	0.06
Restricted Cash	-	0.05	0.05	-	-	0.05
Other Current Assets	-	-	10	-	-	0.1
Total Current Assets	294.32	318.13	266.15	77.75	110.67	130.59
Property, Plant & Equipment	1.06	0.46	1.06	1.52	0.95	0.42
Long-Term Deferred Charges	-	-	0.56	3.98	1.65	-
Other Long-Term Assets	7.2	7.18	4.09	0.05	0.05	-
Total Assets	302.57	325.76	271.87	83.3	113.33	131
Accounts Payable	1.56	1.34	0.53	3.44	2.52	0.81
Accrued Expenses	11.9	14.37	14.66	4.32	2.84	0.43
Current Portion of Leases	0.37	-	0.34	0.32	0.16	0.11
Other Current Liabilities	0.15	0.2	10.36	1.64	0.23	0.14
Total Current Liabilities	13.97	15.92	25.89	9.72	5.75	1.48
Long-Term Leases	0.3	-	-	0.28	-	-
Other Long-Term Liabilities	-	-	0.07	0.38	0.71	0.08
Total Liabilities	14.27	15.92	25.96	10.37	6.47	1.56
Common Stock	0.05	0.05	0.04	0	0	0
Additional Paid-In Capital	560.28	553.21	400.17	6.04	2.31	0.16
Retained Earnings	-272.02	-243.47	-154.45	-82.86	-45.2	-20.46
Comprehensive Income & Other	-0.02	0.06	0.14	-	-	-
Total Common Equity	288.3	309.85	245.91	-76.83	-42.89	-20.3
Shareholders' Equity	288.3	309.85	245.91	72.92	106.86	129.45
Total Liabilities & Equity	302.57	325.76	271.87	83.3	113.33	131
Total Debt	0.67	-	0.34	0.6	0.16	0.11
Net Cash (Debt)	288.89	313.44	252.81	74.94	109.87	130.26
Net Cash Growth	-9.79%	23.98%	237.37%	-31.79%	-15.66%	-
Net Cash Per Share	5.89	6.66	7.11	23.99	14.06	26.12
Filing Date Shares Outstanding	49.07	49	41.35	12.1	11.64	4.99
Total Common Shares Outstanding	49.04	48.94	41.29	12.1	11.64	4.99
Working Capital	280.35	302.21	240.26	68.04	104.92	129.11
Book Value Per Share	5.88	6.33	5.96	-6.35	-3.68	-4.07
Tangible Book Value	288.3	309.85	245.91	-76.83	-42.89	-20.3
Tangible Book Value Per Share	5.88	6.33	5.96	-6.35	-3.68	-4.07
Machinery	1.4	1.38	1.41	1.26	0.65	0.46

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q